Genetics of common disease: implications for therapy, screening and redefinition of disease
Open Access
- 29 August 1997
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 352 (1357) , 1051-1055
- https://doi.org/10.1098/rstb.1997.0084
Abstract
Susceptibility to most common human diseases is, at least in part, determined by genetic factors. Rapid progress is being made in defining these genetic determinants for a range of diseases including breast cancer, colon cancer, diabetes, arthritis and dementia. The ability to define susceptibility in genetic terms has already led to a reclassification of some of these diseases on genetic and mechanistic grounds. This information is likely to have a profound effect on our approach to human diseases as it will allow a better definition of these disorders, permitting more effective therapeutic intervention, and will lead to both a more precise understanding of the natural history of these diseases and the possibility of identifying populations at risk. An understanding of the mechanisms underlying disease susceptibilty will also improve our ability to develop rational therapeutic interventions for many of these diseases. The role of genetic screening in these common diseases will be discussed, particularly in regard to the application of health care in populations.Keywords
This publication has 12 references indexed in Scilit:
- Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)Nature, 1996
- Lessons from Hereditary Colorectal CancerCell, 1996
- Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12Nature Genetics, 1996
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- BRCA1 is secreted and exhibits properties of a graninNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's diseaseAnnals of Neurology, 1995
- Positional cloning of the mouse obese gene and its human homologueNature, 1995
- Familial Hyperglycemia Due to Mutations in Glucokinase -- Definition of a Subtype of Diabetes MellitusNew England Journal of Medicine, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992